NOP16: A Potential Drug Target and Biomarker (G51491)

Target Name: NOP16

NCBI ID: G51491

NOP16

NOP16: A Potential Drug Target and Biomarker

Nucleolar proteins play a critical role in the regulation of nuclear kernel structure and function. Among them, NOP16 is an important nucleolar protein that has been found to be related to a variety of diseases, including nervous system development, tumors, and aging. In recent years, researchers have conducted in-depth studies on the function and mechanism of NOP16 and discovered its important role in the biomedical field. This article will discuss the discovery, function, mechanism of action, potential as a drug target and clinical application of NOP16.

1. Discovery of NOP16

NOP16 is a protein belonging to the Hsp70 family and is highly abundant in mammalian cells. It was first discovered in 1997 by American scientists Stanley B. Korsmeyer and Thomas R. Cepeda from mouse embryonic stem cells. NOP16 is unique and conserved in mammalian cells, and its gene coding region is located on the X chromosome.

2. Functions of NOP16

1. Participate in nucleolus formation and function

NOP16 is one of the main components of the nucleolus. It is located in the nucleolus at the binding site of Nup100 and Nup120. By binding to Nup100 and Nup120, NOP16 can promote nucleolar assembly and stability. In addition, NOP16 is also involved in regulating nucleolus size and morphology, thereby affecting the interaction between nucleolus and rRNA, and affecting the formation and function of ribosomes.

2. Participate in nervous system development

Research shows that NOP16 plays an important role in the development of the nervous system. During embryonic life, NOP16 is a key factor in neuronal nuclear differentiation. During adulthood, NOP16 is involved in neuronal survival and apoptosis, maintaining the stability and plasticity of neuronal networks.

3. Participate in tumor occurrence and development

NOP16 is expressed in a variety of tumors, including breast cancer, lung cancer, and prostate cancer. Studies have shown that the expression level of NOP16 is related to tumor invasion and metastasis. In addition, NOP16 is also involved in the apoptosis of tumor cells and may have a potential role in tumor treatment.

4. Participate in the aging process

As we age, the content of NOP16 gradually decreases in cells. This phenomenon is closely related to cellular aging. Research shows that the reduction of NOP16 may be a major factor in cellular aging. Therefore, by restoring the expression level of NOP16, anti-aging can be achieved, which has potential significance for the treatment of aging-related diseases.

3. The mechanism of action of NOP16

1. Acts on Nup100 and Nup120

NOP16 activates the Nup100-dependent KH domain and YY motif by binding to Nup100 and Nup120, thereby promoting rRNA binding and transcription. These transcription products include mRNA, rRNA and proteins, which can provide necessary components for ribosome formation.

2. Act on the combination of Nup100 and Nup120

NOP16 can regulate the phosphorylation levels of Nup100 and Nup120 by binding to Nup100 and Nup120. Phosphorylation is an important metabolic process in cells and plays a key role in cell metabolism. By regulating the phosphorylation levels of Nup100 and Nup120, NOP16 can affect nucleolar assembly and stability.

3. Act on the cell cycle

NOP16 is expressed in the G1 phase, S phase and G2 phase cell cycle, but the expression levels are different. In the G1 phase, the expression level of NOP16 is the highest, followed by the S phase, and the lowest in the G2 phase. This may be related to the fact that NOP16 plays different biological functions in different stages of the cell cycle.

4. The potential of NOP16 as a drug target

1. NOP16 as an anti-tumor drug target

NOP16 is expressed in a variety of tumors and thus by inhibiting

Protein Name: NOP16 Nucleolar Protein

The "NOP16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NOP16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets